Literature DB >> 17641831

Impairment of myocardial and skeletal mitochondria in mice with viral myocarditis and their correlation.

Jin Wei1, Dengfeng Gao, Xiaolin Niu, Jian Liu, Mingxia Chen.   

Abstract

In order to investigate the impairment of mitochondrial membrane phospholipid localization and DNA(3867) (mtDNA(3867)) deletion and the correlation between cardiac and skeletal muscle cells in mice with viral myocarditis, 50 BALB/c mice were divided into two groups randomly. In experimental group (n=40), the mice were intraperitoneally injected with 0.1 mL Eagle liquid with CVB3(TCID50=10(8)), while in the control group (n=10), the mice were subjected to equal volume of Eagle liquid. The impairment of mitochondrial membrane phospholipid localization and mtDNA(3867) deletion rate of cardiac and skeletal muscle were detected separately at day 3, 11 and 24 after injection. The correlation of mitochondrial membrane phospholipid localization and mtDNA(3867) deletion rate between cardiac and skeletal muscle cells cells was analyzed using Spearman method. At the day 3 after injection, in both cardiac and skeletal muscle cells, mtDNA(3867) deletion rate was significantly higher in experimental group than in control group (P<0.05), but the localization of mitochondrial membrane phospholipid showed no difference between two groups (P>0.05). At day 11 after injection, the mtDNA(3867) deletion rate of both cells in experimental group was increased to the peak level (P<0.05), and the impairment of mitochondrial membrane phospholipid localization of both cells also increased markedly in experimental group as compared with control group (P>0.05). At the day 24 after injection, the impairment of mitochondrial membrane phospholipid localization and mtDNA(3867) deletion of both cells showed a recovery tendency, but still severer than those at the day 3 after injection (P<0.05). The impairment of mitochondrial membrane phospholipid localization and mtDNA(3867) deletion were consistent and synchronistic between cardiac and skeletal muscle cells, and showed good correlations (P<0.05). The impairment of mitochondria plays an important role in the pathogenesis of viral myocarditis, and the skeletal muscle cells might act as a peripheral "window" to reflect the mitochondrial damage of cardiac myocytes.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17641831     DOI: 10.1007/s11596-007-0305-9

Source DB:  PubMed          Journal:  J Huazhong Univ Sci Technolog Med Sci        ISSN: 1672-0733


  6 in total

1.  Genomic and template RNA transcription in a model of persistent enteroviral infection.

Authors:  J W Gow; W M Behan; P Cash; K Simpson; P O Behan
Journal:  J Neurovirol       Date:  1997-02       Impact factor: 2.643

Review 2.  Understanding the impact of mitochondrial defects in cardiovascular disease: a review.

Authors:  José Marín-García; Michael J Goldenthal
Journal:  J Card Fail       Date:  2002-10       Impact factor: 5.712

Review 3.  Skeletal muscle disorders in heart failure.

Authors:  P K Lunde; I Sjaastad; H M Schiøtz Thorud; O M Sejersted
Journal:  Acta Physiol Scand       Date:  2001-03

4.  Enteroviral RNA and virus-like particles in the skeletal muscle of patients with idiopathic dilated cardiomyopathy.

Authors:  E Arbustini; M Grasso; E Porcu; O Bellini; M Diegoli; R Fasani; N Banchieri; A Pilotto; P Morbini; B Dal Bello; C Campana; A Gavazzi; M Viganò
Journal:  Am J Cardiol       Date:  1997-11-01       Impact factor: 2.778

5.  Coxsackievirus B3-associated myocardial pathology and viral load reduced by recombinant soluble human decay-accelerating factor in mice.

Authors:  Bobby Yanagawa; O Brad Spiller; Jonathan Choy; Honglin Luo; Paul Cheung; Huifang M Zhang; Ian G Goodfellow; David J Evans; Agripina Suarez; Decheng Yang; Bruce M McManus
Journal:  Lab Invest       Date:  2003-01       Impact factor: 5.662

6.  A deletion of mitochondrial DNA in murine doxorubicin-induced cardiotoxicity.

Authors:  K Adachi; Y Fujiura; F Mayumi; A Nozuhara; Y Sugiu; T Sakanashi; T Hidaka; H Toshima
Journal:  Biochem Biophys Res Commun       Date:  1993-09-15       Impact factor: 3.575

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.